Study S000033

The Effects of Tirzepatide in Young Adults With Prader-Willi Syndrome, Hypothalamic Obesity and General Non-Syndromic Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06901245
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 36
Start: 2025-05-01
Primary completion: 2026-06
Lead sponsor: Grace Kim
Conditions: Prader-Willi Syndrome; Hypothalamic Obesity; Obesity/Therapy
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: OTHER_GRANT:I8F-NS-I001

Registered primary outcomes

Change in weight [48 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.